“…Although ketamine has a large therapeutic window, its use is limited due to low efficacy and huge interindividaul variability in treatment response including ADRs that require cessation of therapy (Kvarnström et al, 2004 ; Noppers et al, 2010 ; Laskowski et al, 2011 ; Hardy et al, 2012 ; Perez-Ruixo et al, 2020 ). Ketamine has been associated with increased blood pressure, alteration of speech, muscular discoordination, euphoria, hallucination, loss of consciousness, seizure, nausea, out of body experience, hypothermia, traffic accident or drowning and irrational behavior (Iyalomhe and Iyalomhe, 2014 ; Lonnée et al, 2018 ; Gajewski et al, 2020 ).…”